全文获取类型
收费全文 | 1537009篇 |
免费 | 115465篇 |
国内免费 | 17838篇 |
专业分类
耳鼻咽喉 | 21510篇 |
儿科学 | 42260篇 |
妇产科学 | 41377篇 |
基础医学 | 211635篇 |
口腔科学 | 43193篇 |
临床医学 | 141692篇 |
内科学 | 291048篇 |
皮肤病学 | 32187篇 |
神经病学 | 117725篇 |
特种医学 | 61440篇 |
外国民族医学 | 573篇 |
外科学 | 227715篇 |
综合类 | 65457篇 |
现状与发展 | 61篇 |
一般理论 | 454篇 |
预防医学 | 104038篇 |
眼科学 | 37691篇 |
药学 | 121591篇 |
192篇 | |
中国医学 | 15210篇 |
肿瘤学 | 93263篇 |
出版年
2021年 | 18497篇 |
2020年 | 13385篇 |
2019年 | 15296篇 |
2018年 | 19461篇 |
2017年 | 16411篇 |
2016年 | 16962篇 |
2015年 | 21817篇 |
2014年 | 28823篇 |
2013年 | 35524篇 |
2012年 | 48414篇 |
2011年 | 52187篇 |
2010年 | 30893篇 |
2009年 | 28109篇 |
2008年 | 44204篇 |
2007年 | 47235篇 |
2006年 | 47999篇 |
2005年 | 46914篇 |
2004年 | 41709篇 |
2003年 | 40350篇 |
2002年 | 38803篇 |
2001年 | 67654篇 |
2000年 | 69864篇 |
1999年 | 60445篇 |
1998年 | 17944篇 |
1997年 | 16781篇 |
1996年 | 15648篇 |
1995年 | 14745篇 |
1994年 | 13543篇 |
1992年 | 44390篇 |
1991年 | 42656篇 |
1990年 | 41631篇 |
1989年 | 40437篇 |
1988年 | 37784篇 |
1987年 | 37062篇 |
1986年 | 35467篇 |
1985年 | 33533篇 |
1984年 | 25079篇 |
1983年 | 21233篇 |
1979年 | 23961篇 |
1978年 | 17049篇 |
1977年 | 14797篇 |
1976年 | 13346篇 |
1975年 | 15250篇 |
1974年 | 18081篇 |
1973年 | 17560篇 |
1972年 | 16823篇 |
1971年 | 15717篇 |
1970年 | 14891篇 |
1969年 | 14338篇 |
1968年 | 13451篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
Tonya J.H. White 《Journal of the American Academy of Child and Adolescent Psychiatry》2019,58(11):1042-1050
33.
Effects of the Clearing the Lung and Dissipating Phlegm Method in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
下载免费PDF全文
![点击此处可从《World Journal of Traditional Chinese Medicine》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Tao Zhang Yao-Hui Li Gai-Xia Liu Xiu-Lin Tang 《World Journal of Traditional Chinese Medicine》2019,(1)
Objective: The objective of this study is to evaluate the efficacy and safety of the clearing the lung and dissipating phlegm method in the treatment of acute exacerbation of chronic obstructive pulmonary disease(COPD) and to provide evidence for the treatment of the disease. Materials and Methods: Literature was searched from the United States National Library of Medicine(PubMed), Embase, Cochrane Library, China National Knowledge Infrastructure, Wanfang Database(Wanfang), and the Full?Text Database of Chinese Scientific and Technical Periodicals(VIP).A comprehensive collection was made of randomized controlled trials(RCTs) before June 2018, in which the treatment groups used either the clearing the lung and dissipating phlegm formulas only or combined it with routine Western medicine therapy, and the control group adopted routine Western medicine therapy only for the acute exacerbation of COPD. The Cochrane risk of bias method was used to evaluate the quality of the literature. The data were analyzed and retrieved independently by two reviewers before meta?analysis was carried out with RevMan 5.3 software to evaluate the primary outcome measures, including the total clinical effective rate, and the secondary outcome measures such as the pulmonary function(forced vital capacity [FVC], forced expiratory volume in the 1 s [FEV1], percentage of FEV1 [FEV1%], and FEV1/FVC)and blood gases(PaO_2 and PaCo_2). Results: A total of 13 RCTs involving 990 patients(496 in the treatment group and 494 in the control group)were included in this study. Meta?analysis revealed significant difference in the efficacy of the group that adopted solely the routine Western medicine method and the group that combined the Western medicine with the clearing the lung and dissipating phlegm method. Outcome measures including the pulmonary function(FVC, FEV1, FEV1%, and FEV1/FVC) and the blood gases(PaO_2 and PaCo_2) were significantly improved as compared to the control group(P 0.00001). However, adverse effects in the treatment group using combined traditional Chinese medicine were not reported due to the short observation time of the study. Conclusion: The clearing the lung and dissipating phlegm method can improve the efficacy in the treatment of acute exacerbation of COPD, the outcome measures of the pulmonary function and the blood gases,as well as the life quality of the patients. However, due to the fact that the existing studies are generally of poor quality in which randomization and its implementation were not properly carried out, more high?quality RCTs are necessary to confirm the findings of this study. 相似文献
34.
35.
36.
37.
目的探讨脑卒中患者急性应激障碍发生现状及影响因素。方法采用斯坦福急性应激反应问卷对349例脑卒中住院患者进行调查。结果共163例(46.70%)患者发生急性应激障碍;Logistic回归分析结果显示,患者性格、是否存在偏瘫及是否吞咽功能障碍是脑卒中患者发生急性应激障碍的主要影响因素(P0.05,P0.01)。结论脑卒中患者急性应激障碍发生率较高,内向性格及存在偏瘫和吞咽功能障碍的患者更容易发生急性应激障碍。医护人员应及时为高危患者提供个体化治疗及预见性护理,防止脑卒中患者发生急性应激障碍。 相似文献
38.
39.
40.
目的:观察非霍奇金淋巴瘤(non-Hodgkin's lymphoma,NHL)患者自体造血干细胞移植(autologous hematopoietic stem cell transplantation,ASCT)术后应用重组人α-2b干扰素(α-2b IFN)进行早期干预治疗的临床疗效。方法:选取18例行ASCT的NHL患者为研究对象,移植前疾病评估均未达到完全缓解(complete remission,CR),试验组血象恢复后给予IFN 3 000 000 U次/隔日干预治疗,3个月后停用;对照组未行干扰素干预治疗,分析总体疗效及两组对比的生存情况。结果:随访中位时间为34(10~50)个月,患者中位生存时间为37(31~45)个月,3年总体无进展生存(progressive free survival,PFS)、总生存(overall survivial,OS)分别为54.7%、66.8%。ASCT后试验组1年内无疾病复发,2年内复发率为12.5%;对照组1年内复发率为20%,2年内复发率为30%。结论:NHL患者在ASCT后给予重组人α-2b IFN早期干预治疗,患者耐受性好,可能降低移植后早期复发率。 相似文献